The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

SAN DIEGO—Cytiva has launched its Sefia next-generation manufacturing platform, with the goal of helping drug developers and larger healthcare providers accelerate their production of chimeric antigen ...

Automated cell therapy manufacturing pioneer Cellares has hit a key milestone, gaining a current Good Manufacturing Practice (cGMP) stamp of approval for its Cell Shuttle factory-in-a-box, which is ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...

Cell Therapy Manufacturers · GlobeNewswire Inc. Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (7th Edition): Trends and Forecast Till 2035 - Distribution by Type of ...

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Wang tells PV Tech Premium that copper offers a ‘a compelling combination’ of traits to replace silver. Image: AIKO. This Premium article, which was one of the most read Premium articles in 2025, has ...